253 related articles for article (PubMed ID: 33470765)
1. The gut microbiota metabolite propionate ameliorates intestinal epithelial barrier dysfunction-mediated Parkinson's disease via the AKT signaling pathway.
Huang T; Shi H; Xu Y; Ji L
Neuroreport; 2021 Feb; 32(3):244-251. PubMed ID: 33470765
[TBL] [Abstract][Full Text] [Related]
2. Butyrate and Propionate Restore the Cytokine and House Dust Mite Compromised Barrier Function of Human Bronchial Airway Epithelial Cells.
Richards LB; Li M; Folkerts G; Henricks PAJ; Garssen J; van Esch BCAM
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374733
[TBL] [Abstract][Full Text] [Related]
3. Differential gene expression in iPSC-derived human intestinal epithelial cell layers following exposure to two concentrations of butyrate, propionate and acetate.
Grouls M; Janssen AWF; Duivenvoorde LPM; Hooiveld GJEJ; Bouwmeester H; van der Zande M
Sci Rep; 2022 Aug; 12(1):13988. PubMed ID: 35977967
[TBL] [Abstract][Full Text] [Related]
4. Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy.
Feng Y; Wang Y; Wang P; Huang Y; Wang F
Cell Physiol Biochem; 2018; 49(1):190-205. PubMed ID: 30138914
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease.
Hou YF; Shan C; Zhuang SY; Zhuang QQ; Ghosh A; Zhu KC; Kong XK; Wang SM; Gong YL; Yang YY; Tao B; Sun LH; Zhao HY; Guo XZ; Wang WQ; Ning G; Gu YY; Li ST; Liu JM
Microbiome; 2021 Jan; 9(1):34. PubMed ID: 33517890
[TBL] [Abstract][Full Text] [Related]
6. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
[TBL] [Abstract][Full Text] [Related]
7. Short-chain fatty acids exert opposite effects on the expression and function of p-glycoprotein and breast cancer resistance protein in rat intestine.
Xie QS; Zhang JX; Liu M; Liu PH; Wang ZJ; Zhu L; Jiang L; Jin MM; Liu XN; Liu L; Liu XD
Acta Pharmacol Sin; 2021 Mar; 42(3):470-481. PubMed ID: 32555444
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic and therapeutic supplementation using fructo-oligosaccharide improves the intestinal homeostasis after mucositis induced by 5- fluorouracil.
Carvalho PLA; Andrade MER; Trindade LM; Leocádio PCL; Alvarez-Leite JI; Dos Reis DC; Cassali GD; Souza E Melo ÉLS; Dos Santos Martins F; Fernandes SOA; Gouveia Peluzio MDC; Generoso SV; Cardoso VN
Biomed Pharmacother; 2021 Jan; 133():111012. PubMed ID: 33254017
[TBL] [Abstract][Full Text] [Related]
9. Bergenin Ameliorates MPTP-Induced Parkinson's Disease by Activating PI3K/Akt Signaling Pathway.
Ji Y; Wang D; Zhang B; Lu H
J Alzheimers Dis; 2019; 72(3):823-833. PubMed ID: 31658061
[TBL] [Abstract][Full Text] [Related]
10. [Effects of short chain fatty acid on barrier disruption of human intestinal epithelial cell induced by endotoxin/lipopolysaccharide and the related mechanism].
Feng YH; Huang YL; Wang P; Wang FJ
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):214-218. PubMed ID: 29690739
[No Abstract] [Full Text] [Related]
11. Parkinson's Disease Is Associated with Impaired Gut-Blood Barrier for Short-Chain Fatty Acids.
Yang X; Ai P; He X; Mo C; Zhang Y; Xu S; Lai Y; Qian Y; Xiao Q
Mov Disord; 2022 Aug; 37(8):1634-1643. PubMed ID: 35607987
[TBL] [Abstract][Full Text] [Related]
12. Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series.
Joers V; Masilamoni G; Kempf D; Weiss AR; Rotterman TM; Murray B; Yalcin-Cakmakli G; Voll RJ; Goodman MM; Howell L; Bachevalier J; Green SJ; Naqib A; Shaikh M; Engen PA; Keshavarzian A; Barnum CJ; Nye JA; Smith Y; Tansey MG
Neurobiol Dis; 2020 Oct; 144():105027. PubMed ID: 32712266
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
[TBL] [Abstract][Full Text] [Related]
14. Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson's disease in mice via modulating gut microbiota and short-chain fatty acids.
Cai B; Zhong L; Wang Q; Xu W; Li X; Chen T
Front Pharmacol; 2023; 14():1198335. PubMed ID: 37388445
[No Abstract] [Full Text] [Related]
15. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
Aho VTE; Houser MC; Pereira PAB; Chang J; Rudi K; Paulin L; Hertzberg V; Auvinen P; Tansey MG; Scheperjans F
Mol Neurodegener; 2021 Feb; 16(1):6. PubMed ID: 33557896
[TBL] [Abstract][Full Text] [Related]
16. Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson's Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein.
Zhong Z; Chen W; Gao H; Che N; Xu M; Yang L; Zhang Y; Ye M
Neurochem Res; 2021 Nov; 46(11):3050-3058. PubMed ID: 34347266
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency.
Liu L; Fu Q; Li T; Shao K; Zhu X; Cong Y; Zhao X
PLoS One; 2022; 17(2):e0262855. PubMed ID: 35108315
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of prucalopride in MPTP-induced Parkinson's disease mice: Neurochemistry, motor function and gut barrier.
Shi Y; Qiao CM; Zhou Y; Wu J; Cui C; Hong H; Jia XB; Huang SB; Yao L; Zhao WJ; Shen YQ
Biochem Biophys Res Commun; 2021 Jun; 556():16-22. PubMed ID: 33836343
[TBL] [Abstract][Full Text] [Related]
19. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease.
Wang F; Qian F; Zhang Q; Zhao J; Cen J; Zhang J; Zhou J; Luo M; Jia C; Rong X; Chu M
Front Immunol; 2023; 14():1124118. PubMed ID: 37398673
[TBL] [Abstract][Full Text] [Related]
20. Effects of banana powder (Musa acuminata Colla) on the composition of human fecal microbiota and metabolic output using in vitro fermentation.
Tian DD; Xu XQ; Peng Q; Zhang YW; Zhang PB; Qiao Y; Shi B
J Food Sci; 2020 Aug; 85(8):2554-2564. PubMed ID: 32677055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
